Akèy › Kansè poumon › Kalifòni › Santa Rosa
Etid klinik pou Kansè poumon nan Santa Rosa, CA
11 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Santa Rosa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Kaiser Permanente-Santa Rosa, Santa Rosa
- Saint Helena Hospital, St. Helena · 14 mi lwen
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ap rekriteFaz 3
- Kaiser Permanente-Santa Rosa, Santa Rosa
Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
- Kaiser Permanente-Santa Rosa, Santa Rosa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Providence Medical Foundation - Santa Rosa, Santa Rosa
- Providence Santa Rosa Memorial Hospital, Santa Rosa
- Saint Helena Hospital, St. Helena · 14 mi lwen
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Kaiser Permanente-Santa Rosa, Santa Rosa
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Sutter Pacific Medical Foundation, Santa Rosa
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Ap rekriteFaz 1/2
- Providence Medical Foundation, Santa Rosa
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Sutter Pacific Medical Foundation, Santa Rosa
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
- St Joseph Heritage Healthcare, Santa Rosa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Sutter Pacific Medical Foundation, Santa Rosa
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Ap rekriteFaz 1/2
- Providence Medical Foundation (site 209), Santa Rosa
Etid Kansè poumon nan lòt vil
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Arlington, VA41 etid
- Washington, DC41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
Lòt etid nan Santa Rosa
- Kansè Poumon ki pa ti selil17 etid
- Kansè (tout kalite)11 etid
- Kansè nan tete11 etid
- Kansè kolorektal11 etid
- Kansè Metastatik9 etid
- Kansè pwostat9 etid
- Kansè ovè7 etid
- Kansè pankreyas6 etid
- Kansè Endomèt6 etid
- Kansè kolon5 etid
- Kansè lestomak5 etid
- Kansè tèt ak kou4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.